Isoflavone aglycons-sulfobutyl ether-β-cyclodextrin inclusion complexes: In solution and solid state studies

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 83, Issue 1-2, 2015, Pages 27-36

  Stancanelli, Rosanna ^a   Venuti, Valentina ^a   Arigo A ^a   Calabro M L ^a   Cannava C ^b   Crupi, V ^a   Majolino, D ^a   Tommasini, S ^a   Ventura, C A ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Dissolution rate; FTIR ATR spectroscopy; Isoflavones; Solubility measurements; Sulfobutyl ether cyclodextrin; UV Vis spectroscopy

Indexed keywords

EID: 84958535970     PISSN: 09230750     EISSN: 15731111     Source Type: Journal    
DOI: 10.1007/s10847-015-0535-6     Document Type: Article

References (51)

1. Reiter, E., Beck, V., Medjakovic, S., Jungbauer, A.: Isoflavones are safe compounds for therapeutical applications-evaluation of in vitro data. Gynecol. Endocrinol. 25, 554-580 (2009)
2. Warri, A., Saarinen, N.M., Makela, S., Hilakivi-Clarke, L.: The role of early life genistein exposures in modifying breast cancer risk. Br. J. Cancer 98, 1485-1493 (2008)
3. Ratna, W.N.: Inhibition of estrogenic stimulation of gene expression by genistein. Life Sci. 71, 865-877 (2002)
4. Mueller, S.O., Simon, S., Chae, K., Metzler, M., Korach, K.S.: Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells. Toxicol. Sci. 80, 14-25 (2004)
5. Jiang, Q., Payton-Stewart, F., Elliott, S., Driver, J., Rhodes, L.V., Zhang, Q., Zheng, S., Bhatnagar, D., Boue, S.M., Collins-Burow, B.M., Sridhar, J., Stevens, C., McLachlan, J.A., Wiese, T.E., Burow, M.E., Wang, G.: Effects of 7-O substitutions on estrogenic and anti-estrogenic activities of daidzein analogues in MCF-7 breast cancer cells. J. Med. Chem. 53, 6153-6163 (2010)
6. Barbosa, A.C., Lajolo, F.M., Genovese, M.I.: Effect of free or protein-associated soy isoflavones on the antioxidant status in rats. J. Sci. Food Agric. 91, 721-731 (2011)
7. Byun, J.S., Lee, S.S.: Effect of soybeans and sword beans on bone metabolism in a rat model of osteoporosis. Ann. Nutr. Metab. 56, 106-112 (2010)
8. Ruijter, J., Valstar, M.J., Narajczyk, M., Wegrzyn, G., Kulik, W., Ijist, L., Wagemans, T., van der Wal, W.M., Wijburg, F.A.: Genistein in Sanfilippo disease: a randomized controlled crossover tria. Ann. Neurol. 71, 110-120 (2012)
9. Uckun, F.M., Evans, W.E., Forsyth, C.J., Waddick, K.G., Ahlgren, L.T., Chelstrom, L.M., Burkhardt, A., Bolen, J., Myers, D.E.: Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases. Science 267, 886-891 (1995)
10. Rusin, A., Krawczyk, Z., Grynkiewicz, G., Gogler, A., Zawisza-Puchałka, J., Szeja, W.: Synthetic derivatives of genistein, their properties and possible applications. Acta Biochim. Pol. 57, 23-34 (2010)
11. Si, H.Y., Li, D.P., Wang, T.M., et al.: Improving the anti-tumor effect of genistein with a biocompatible superparamagnetic drug delivery system. J. Nanosci. Nanotechnol. 10, 2325-2331 (2010)
12. Zhang, Z.W., Huang, Y., Gao, F., Bu, H.H., Gu, W.W., Li, Y.P.: Daidzein-phospholipid complex loaded lipid nanocarriers improved oral absorption: in vitro characteristics and in vivo behaviour in rats. Nanoscale 3, 1780-1787 (2011)
13. Loftsson, T., Brewster, M.E.: Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J. Pharm. Sci. 85, 1017-1025 (1996)
14. Loftsson, T., Brewster, M.E.: Pharmaceutical applications of cyclodextrins: basic science and product development. J. Pharm. Pharmacol. 62, 1607-1621 (2010)
15. Tolman, J.A., Nelson, N.A., Son, Y.J., Bosselmann, S., Wiederhold, N.P., Peters, J.I., McConville, J.T., Williams III, R.O.: Characterization and pharmacokinetic analysis of aerosolized aqueous voriconazole solution. Eur. J. Pharm. Biopharm. 72, 199-205 (2009)
16. Savolainen, J., Järvinen, K., Matilainen, L., Järvinen, T.: Improved dissolution and bioavailability of phenytoin by sulfobutylether-β-cyclodextrin (SBE)7 M-β-CD) and hydroxypropyl-β-cyclodextrin (HP-β-CD) complexation. Int. J. Pharm. 165, 69-78 (1998)
17. García-Río, L., Méndez, M., Paleo, M.R., Sardina, F.J.: New insights in cyclodextrin: surfactant mixed systems from the use of neutral and anionic cyclodextrin derivatives. J. Phys. Chem. B 111, 12756-12764 (2007)
18. ® (sulfobutyl ether β-cyclodextrin). J. Pharm. Sci. 92, 922-926 (2003)
19. ®) on the dissolution properties of a poorly soluble drug from extrudates prepared by hot-melt extrusion. Int. J. Pharm. 350, 188-196 (2008)
20. Qu, Q., Tucker, E., Christian, S.D.: Sulfoalkyl ether β-cyclodextrin derivatives: synthesis and characterizations. J. Incl. Phenom. Macrocycl. Chem. 43, 213-221 (2002)
21. Sotthivira, S., Haslam, J.L., Stella, V.J.: Evaluation of various properties of alternative salt forms of sulfobutylether-β-cyclodextrin, (SBE)7 M-β-CD. Int. J. Pharm. 330, 73-81 (2007)
22. Song, A.J., Wang, J.H., Liu, C.D., Deng, L.H.: Sulfoalkyl ether β-cyclodextrin derivatives synthesized by a single step method as pharmaceutical biomaterials. Chin. Sci. Bull. 54, 3187-3199 (2009)
23. Loftsson, T., Magnusdottir, A., Masson, M., Sigurjonsdottir, J.F.: Self-association and cyclodextrin solubilization of drugs. J. Pharm. Sci. 91, 2307-2316 (2002)
24. Loftsson, T., Masson, M., Brewster, M.E.: Self-association of cyclodextrin and cyclodextrin complexes. J. Pharm. Sci. 93, 1091-1099 (2004)
25. Stella, V.J., He, Q.: Cyclodextrins. Toxicol. Pathol. 36, 30-42 (2008)
26. Messner, M., Kurkov, S.V., Jansook, P., Loftsson, T.: Selfassembled cyclodextrin aggregates and nanoparticles. Int. J. Pharm. 387, 199-208 (2010)
27. Irie, T., Uekama, K.: Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J. Pharm. Sci. 86, 147-162 (1997)
28. Stella, V.J., Rajewski, R.A.: Cyclodextrins: their future in drug formulation and delivery. Pharm. Res. 14, 556-567 (1997)
29. Rajewski, R.A., Traiger, G., Bresnahan, J., Jaberaboansri, P., Stella, V.J., Thompson, D.O.: Preliminary safety evaluation of parenterally administrated sulfoalkyl ether β-cyclodextrin derivatives. J. Pharm. Sci. 84, 927-932 (1995)
30. Sotthivirat, S., Haslam, J.L., Stella, V.J.: Evaluation of various properties of alternative salt forms of sulfobutylether-β-cyclodextrin, (SBE)7 M-β-CD. Int. J. Pharm. 330, 73-81 (2007)
31. Xiao, D., Yang, B., Zhao, Y.L., Liao, X.L., Yang, X.M., Wang, F., Chen, Y.J., Zhou, R.G.: Inclusion complexes of dihydroartemisinin with cyclodextrin and its derivatives: characterization, solubilization and inclusion mode. J. Incl. Phenom. Macrocycl. Chem. 79, 349-356 (2014)
32. Cannavà, C., Crupi, V., Guardo, M., Majolino, D., Stancanelli, R., Tommasini, S., Ventura, C.A., Venuti, V.: Phase solubility and FTIR-ATR studies of idebenone/sulfobutyl ether β-cyclodextrin inclusion complex. J. Incl. Phenom. Macrocycl. Chem. 75, 255-262 (2013)
33. Crupi, V., Ficarra, R., Guardo, M., Majolino, D., Stancanelli, R., Venuti, V.: UV-Vis and FTIR-ATR spectroscopic techniques to study the inclusion complexes of genistein with β-cyclodextrins. J. Pharm. Biomed. Anal. 44, 110-117 (2007)
34. Stancanelli, R., Mazzaglia, A., Tommasini, S., Calabrò, M.L., Guardo, M., Villari, V., Ficarra, P., Ficarra, R.: The enhancement of isoflavones water solubility by complexation with modified cyclodextrins: a spectroscopic investigation with implications in the pharmaceutical analysis. J. Pharm. Biomed. Anal. 44, 980-984 (2007)
35. Cannavà, C., Crupi, V., Ficarra, P., Guardo, M., Majolino, D., Stancanelli, R., Venuti, V.: Physicochemical characterization of coumestrol/β-cyclodextrins inclusion complexes by UV-Vis and FTIR-ATR spectroscopies. Vib. Spectrosc. 48, 172-178 (2008)
36. Crupi, V., Majolino, D., Paciaroni, A., Stancanelli, R., Venuti, V.: Influence of the "host-guest" interactions on the mobility of genistein/β-cyclodextrin inclusion complex. J. Phys. Chem. B 113, 11032-11038 (2009)
37. Cannavà, C., Crupi, V., Ficarra, P., Guardo, M., Majolino, D., Mazzaglia, A., Stancanelli, R., Venuti, V.: Physico-chemical characterization of an amphiphilic cyclodextrin/genistein complex. J. Pharm. Biomed. Anal. 51, 1064-1068 (2010)
38. Crupi, V., Majolino, D., Paciaroni, A., Rossi, B., Stancanelli, R., Venuti, V., Viliani, G.: The effect of hydrogen bond on the vibrational dynamics of genistein free and complexed with β-cyclodextrins. J. Raman Spectrosc. 41, 764-770 (2010)
39. Daruhazi, A.E., Szente, L., Balogh, B., Matyus, P., Beni, S., Takacs, M., et al.: Utility of cyclodextrins in the formulation of genistein: Part 1. Preparation and physicochemical properties of genistein complexes with native cyclodextrins. J. Pharm. Biomed. Anal. 48, 636-640 (2008)
40. Xavier, C.R., Silva, A.P.C., Schwingel, L.C., Borghetti, G.S., Koester, L.S., Mayorga, P., Teixeira, H.F., Bassani, V.L., Lula, I.S., Sinisterra, R.D.: Improvement of genistein content in solid genistein/β-cyclodextrin complexes. Quim. Nova 33, 587-590 (2010)
41. Higuchi, T., Connors, K.A.: Phase-solubility techniques. Adv. Anal. Chem. Instrum. 4, 117-212 (1965)
42. Gibaud, S., Zirar, S.B., Mutzenhardt, P., Fries, I., Astier, A.: Melarsoprol-cyclodextrins inclusion complexes. Int. J. Pharm. 306, 107-121 (2005)
43. Crupi, V., Longo, F., Majolino, D., Venuti, V.: Vibrational properties of water molecules adsorbed in different zeolitic frameworks. J. Phys. 18, 3563-3580 (2006)
44. Brewster, M.E., Loftsson, T.: Cyclodextrins as pharmaceutical solubilizers. Adv. Drug Deliv. Rev. 59, 645-666 (2007)
45. Loftsson, T., Hreinsdóttir, D., Másson, M.: Evaluation of cyclodextrin solubilization of drugs. Int. J. Pharm. 302, 18-28 (2005)
46. Singh, H., Singh, S., Srivastava, A., Tandon, P., Bharti, P., Kumar, S., Maurya, R.: Conformational analysis and vibrational study of daidzein by using FT-IR and FT-Raman spectroscopies and DFT calculations. Spectrochim. Acta Part A 120, 405-415 (2014)
47. Li, N., Liu, J., Zhao, X., Gao, Y., Zhang, L., Zhang, J., Yu, L.: Complex formation of ionic liquid surfactant and β-cyclodextrin. Colloids Surf. A 292, 196-201 (2007)
48. Hamidi, H., Abderrahim, R., Meganem, F.: Spectroscopic studies of inclusion complex of β-cyclodextrin and benzidine diammonium dipicrate, Spectrochim. Acta Part A: Mol. Biomol. Spectrosc. 75, 32-36 (2010)
49. Gavira, J.M., Hernanz, A., Bratu, I.: Dehydration of β-cyclodextrin: an IR ν(OH) band profile analysis. Vib. Spectrosc. 32, 137-146 (2003)
50. Stancanelli, R., Ficarra, R., Cannavà, C., Guardo, M., Calabrò, M.L., Ficarra, P., Ottanà, R., Maccari, R., Crupi, V., Majolino, D., Venuti, V.: UV-Vis and FTIR-ATR characterization of 9-fluorenon-2-carboxyester/(2-hydroxypropyl)-β-cyclodextrin inclusion complex. J. Pharm. Biomed. Anal. 47, 704-709 (2008)
51. Bratu, I., Veiga, F., Fernandes, C., Hernanz, A., Gavira, J.M.: Infrared spectroscopic study of triacetyl-β-cyclodextrin and its inclusion complex with nicapiridine. Spectroscopy 18, 459-467 (2004)